CALL FOR PAPERS: Submit your manuscript today!
Aims & Scope
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy provides targeted peer-reviewed research that advances the understanding of immune responses and the use of immunological methods for therapeutic purposes.
Fully refereed, peer-reviewed articles and short communications present current findings in the development and characterization of mAbs across all therapeutic areas. Development of mAbs for all research applications, including probes, inhibitors, and diagnostic reagents, is also described.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy covers:
- Isolation and production methods
- Characterization, epitope mapping
- Delivery systems for immunotherapeutic and experimental purposes
- Application of mAbs to elucidate signaling pathways
- Development of immunotherapeutic compounds
- Generation of probes for molecular monitoring
- Creation of diagnostic reagents, experimental and clinical
- Analysis of mAb antagonistic/inhibitory effects
- Cellular and molecular responses to mAb immunization
- Immunoscreening for identification of molecular variants and markers
- New sources for availability of fully characterized mAbs
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is under the editorial leadership of Editor Zenon Steplewski, Biotechnology Foundation Inc., Philadelphia, PA, and other leading investigators. View the entire editorial board.
Audience: Cell biologists, immunologists, molecular biologists, among others
Derwent Drug File;